H-EGPRNQDWL-OH

Ref. 3D-PP47938

Información del producto

• Nombre: H-EGPRNQDWL-OH

Descripción

Peptide H-EGPRNQDWL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EGPRNQDWL-OH include the following: A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control Z Xu , N Chokkalingam , E Tello-Ruiz, MC Wise - Cancer immunology , 2020 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/8/11/1354/469840 Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance X Gao, Y Wu, JM Chick , A Abbott, B Jiang , DJ Wang - Cell reports, 2023 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(23)00325-X.pdf Design of Agonistic Altered Peptides for the Robust Induction of CTL Directed towards H-2Db in Complex with the Melanoma-Associated Epitope gp100 MJB van Stipdonk, D Badia-Martinez , M Sluijter - Cancer research, 2009 - AACRhttps://aacrjournals.org/cancerres/article-abstract/69/19/7784/550084 Going Pro to enhance T-cell immunogenicity: E asy as π? HD Hickman , JW Yewdell - European journal of immunology, 2013 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201344095 Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity CM Backlund , RL Holden - Proceedings of the , 2022 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2204078119 Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity B Engels, VH Engelhard , J Sidney , A Sette , DC Binder - Cancer cell, 2013 - cell.comhttps://www.cell.com/cancer-cell/pdf/S1535-6108(13)00128-1.pdf

• Marca: Biosynth